Securities code: 300511 securities abbreviation: Shanghai Xuerong Biotechnology Co.Ltd(300511) Announcement No.: 2022-011 bond Code: 123056 bond abbreviation: Xuerong convertible bond
Shanghai Xuerong Biotechnology Co.Ltd(300511)
Announcement of resolutions of the 30th meeting of the Fourth Board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of directors
1. The board of directors was convened by Mr. Yang Yongping, chairman of the board of directors. The notice of the meeting was sent by e-mail and other communication methods on February 16, 2022.
2. The meeting of the board of directors was held in the conference room of Shanghai Xuerong Biotechnology Co.Ltd(300511) (hereinafter referred to as “the company”) on February 23, 2022, and the voting was conducted by combining on-site and communication.
3. There are 7 directors who should attend the meeting, and 7 actually attended the meeting.
4. The board of directors was presided over by Mr. Yang Yongping, chairman of the board of directors, and the supervisors and senior managers of the company attended the board of directors as nonvoting delegates.
5. The convening, convening and voting procedures of this board meeting comply with the relevant provisions of the company law and other laws, regulations and the articles of association, and are legal and effective.
2、 Deliberations of the board meeting
1. The proposal on providing guarantee for the subsidiary Lintao Xuerong to apply for comprehensive credit to Shanghai Pudong Development Bank Co.Ltd(600000) was deliberated and adopted
Lintao Shanghai Xuerong Biotechnology Co.Ltd(300511) Technology Co., Ltd., the holding subsidiary of the company, decided to apply to Shanghai Pudong Development Bank Co.Ltd(600000) Lanzhou Branch for comprehensive credit of no more than 30 million yuan (including 30 million yuan) according to the needs of production and operation. The company intends to provide joint and several liability guarantee for this credit.
For details, see the announcement on providing guarantee for the subsidiary Lintao Xuerong to apply for comprehensive credit to Shanghai Pudong Development Bank Co.Ltd(600000) published on the gem information disclosure website designated by the CSRC.
The proposal was adopted with 7 affirmative votes, 0 negative votes and 0 abstention.
This proposal needs to be submitted to the general meeting of shareholders of the company for deliberation and approval.
2. The proposal on the company’s application for comprehensive credit to Bank Of Communications Co.Ltd(601328) was deliberated and adopted
According to the needs of production and operation, the company decided to apply to Bank Of Communications Co.Ltd(601328) Shanghai Fengxian sub branch for a comprehensive credit of no more than 150 million yuan (including 150 million yuan), and the guarantee method is credit.
The proposal was adopted with 7 affirmative votes, 0 negative votes and 0 abstention.
3. The proposal on the company’s application for credit line from China Construction Bank Corporation(601939) was deliberated and adopted
According to the needs of production and operation, the company decided to apply to China Construction Bank Corporation(601939) Shanghai Fengxian sub branch for a credit line of no more than 50 million yuan (including 50 million yuan), and the guarantee method is credit.
The proposal was adopted with 7 affirmative votes, 0 negative votes and 0 abstention.
4. The proposal on convening the second extraordinary general meeting of shareholders in 2022 was deliberated and adopted
The company will hold the second extraordinary general meeting of shareholders in 2022 at 1487 Huifeng West Road, Fengxian District, Shanghai ( Shanghai Xuerong Biotechnology Co.Ltd(300511) conference room) at 14:30 p.m. on March 11, 2022. The meeting adopts the combination of on-site voting and online voting.
For details, please refer to the notice on convening the second extraordinary general meeting of shareholders in 2022 published by the company on the gem information disclosure website designated by the CSRC.
The proposal was adopted with 7 affirmative votes, 0 negative votes and 0 abstention.
3、 Documents for future reference
1. Resolution of the 30th meeting of the 4th board of directors of the company.
It is hereby announced.
Shanghai Xuerong Biotechnology Co.Ltd(300511) board of directors February 24, 2022
